NCT03277482 2025-05-31Durvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerDana-Farber Cancer InstitutePhase 1 Terminated16 enrolled
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts